Cargando…
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
Currently, several α-synuclein immunotherapies are being tested in experimental Parkinson’s disease models and in clinical trials. Recent research has revealed that α-synuclein is not just an intracellular synaptic protein but also exists extracellularly. Moreover, the transfer of misfolded α-synucl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923719/ https://www.ncbi.nlm.nih.gov/pubmed/26406122 http://dx.doi.org/10.3233/JPD-150630 |